Control of Trichomoniasis

NCT ID: NCT00334555

Last Updated: 2009-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

599 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-05-31

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to try to find the best method of partner notification and treatment for partners of women with trichomonas

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To carry out a randomized trial to compare the effectiveness of three methods of partner notification and treatment for sexual partners of women with vaginal trichomoniasis - patient self-referral of partners (the current practice standard), delivery of curative therapy to partners by patients themselves, or public health style Disease Intervention carried out by a specially trained Disease Intervention Specialists (DIS) locating the partners and delivering the medication in the field. Reinfection rates with trichomonas at three months of follow-up among the index women will be the measure of effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trichomoniasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

usual care

patient told to refer her partner for treatment

Group Type ACTIVE_COMPARATOR

different methods of partner notification

Intervention Type OTHER

comparing patient referral, partner delivered medications and field intervention to treat sex partners

partner delivered meds

Intervention Type OTHER

patient given meds to give to her partner

field intervention

Intervention Type OTHER

health worker finds partners

partner delivered

patient given medication to deliver to her partners

Group Type ACTIVE_COMPARATOR

partner delivered meds

Intervention Type OTHER

patient given meds to give to her partner

field intervention

Intervention Type OTHER

health worker finds partners

field intervention

field intervention to find partners

Group Type ACTIVE_COMPARATOR

field intervention

Intervention Type OTHER

health worker finds partners

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

different methods of partner notification

comparing patient referral, partner delivered medications and field intervention to treat sex partners

Intervention Type OTHER

partner delivered meds

patient given meds to give to her partner

Intervention Type OTHER

field intervention

health worker finds partners

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age {\> 15 years} Culture or wet prep proven T. vaginalis infection Willingness to provide informed consent and take part in study procedures

\-

Exclusion Criteria

Infection with other STD pathogens requiring Health Dept DIS intervention (syphilis or HIV) Pregnancy or currently breast feeding Recent (8 hours) ingestion of alcoholic beverages or intent to do so in the 24 hours following treatment Allergy to metronidazole The presence of a sexual partner in the clinic at the time of enrollment A history of referral by a partner already treated for trichomoniasis Report of more than four sexual partners in the preceding 30 days
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Alabama at Birmingham

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jane Schwebke, MD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jefferson County Department of Health STD Clinic

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AI050718

Identifier Type: NIH

Identifier Source: secondary_id

View Link

F020508005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.